Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY: DGX )

139.20 -1.32 (-0.94%)
Official Closing Price Updated: 7:00 PM EDT, May 18, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,057,585
Open 139.51
Bid (Size) 128.00 (1)
Ask (Size) 142.08 (1)
Prev. Close 140.52
Today's Range 138.22 - 140.33
52wk Range 125.77 - 174.16
Shares Outstanding 122,180,759
Dividend Yield 1.61%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Quest Diagnostics Incorporated (NYSE:DGX) Shareholder Notice: Investigation over Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 05/12/2022 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Quest Diagnostics Incorporated. 
Via SBWire
7 Defensive Dividend Healthcare Stocks to Buy Now
As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense. 
Via InvestorPlace

Performance

YTD
-15.30%
-15.30%
1 Month
+4.47%
+4.47%
3 Month
+6.17%
+6.17%
6 Month
-5.95%
-5.95%
1 Year
+5.45%
+5.45%

More News

Read More
7 Oversold Stocks That Shouldn’t Be. Buy Them Now.
Via InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Analyst Ratings for Quest Diagnostics
Via Benzinga
Analyst Ratings For Quest Diagnostics
Via Benzinga
Quest Diagnostics Secures CDC Contract To Support COVID-19 Research
Via Benzinga
Quest Diagnostics' COVID-19 Testing Sales Decline 28% In Q1; Lifts FY22 EPS Guidance
Via Benzinga
Quest Diagnostics: Q1 Earnings Insights
Via Benzinga
Quest Diagnostics Announces Organizational Changes to Accelerate Growth and Drive Operational Excellence
Via 3BL Media
Quest Diagnostics's Earnings: A Preview
Via Benzinga
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 4, 2022
Via Benzinga
Earnings Scheduled For April 21, 2022
Via Benzinga
Positive Drug Tests Among US Workers Higher Than In Last 20 Years; Does That Include Cannabis?
Via Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Via Benzinga
Quest Diagnostics Incorporated (NYSE:DGX) Investor Notice: Investigation over Possible Securities Laws Violations
Via SBWire
7 Healthcare Stocks to Buy for the Long Term
Via InvestorPlace
This Foreboding Sign Looms Over Quest Diagnostics's Chart
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Development of Novel Innovative Diagnostic tests Generating Huge Revenue Opportunity for Global Blood Testing Market
Via FinancialNewsMedia
Exposures COVID-19
What 8 Analyst Ratings Have To Say About Quest Diagnostics
Via Benzinga
Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services
Via Benzinga
FORTUNE Magazine Names Quest Diagnostics One of 2022 "World's Most Admired Companies" For Eighth Consecutive Year
Via 3BL Media
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.